Google
 
Google

World Stem Cell Summit 2010

Thursday, September 24, 2009

Oncogene - Table of Contents alert Volume 28 Issue 38

ONCOGENE

September 2009 Volume 28 Number 38, pp 3345 - 3428

---------------------------------------------------------------------

What if you could wield the full power of next-gen sequencing affordably?

What if you could study populations large enough to be statistically significant?
Introducing Agilent's[TM] SureSelect Target Enrichment System, a DNA capture
platform for sequencing studies of any size. With SureSelect, you see just
the genomic regions that matter to you. Learn more at:
http://links.ealert.nature.com/ctt?kn=43&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0


---------------------------------------------------------------------

ONCOGENE - celebrating over 20 years of shaping the scientific community.

Your complete resource for the latest developments in cancer research.

Visit the website at http://links.ealert.nature.com/ctt?kn=49&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

---------------------------------------------------------------------

Call for papers!

Submit your best work in the field of oncogenes, including mechanism
of activation, structure and function of encoded proteins; DNA
and RNA tumor viruses and all other aspects of structure and
function.

Our online submission process is easy and can assist you in becoming
part of this distinguished journal. To learn about the benefits
of submitting your paper to Oncogene, visit
http://links.ealert.nature.com/ctt?kn=32&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0


----------------------
REVIEW
----------------------
Genetic predisposition to human disease: allele-specific expression and low-penetrance regulatory loci
A de la Chapelle
Abstract: http://links.ealert.nature.com/ctt?kn=40&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=57&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

----------------------
ORIGINAL ARTICLES
----------------------
Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation
S Hegde, S Ni, S He, D Yoon, G S Feng, S S Watowich, R F Paulson and P A Hankey
Abstract: http://links.ealert.nature.com/ctt?kn=58&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=55&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
K-H Lee, Y-L Chen, S-D Yeh, M Hsiao, J-T Lin, Y-G Goan and P-J Lu
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=53&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers
H Ebi, T Sato, N Sugito, Y Hosono, Y Yatabe, Y Matsuyama, T Yamaguchi, H Osada, M Suzuki and T Takahashi
Abstract: http://links.ealert.nature.com/ctt?kn=54&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=48&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
T Cherrier, S Suzanne, L Redel, M Calao, C Marban, B Samah, R Mukerjee, C Schwartz, G Gras, B E Sawaya, S L Zeichner, D Aunis, C Van Lint and O Rohr
Abstract: http://links.ealert.nature.com/ctt?kn=50&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=59&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling
A H Palamakumbura, S R Vora, M A Nugent, K H Kirsch, G E Sonenshein and P C Trackman
Abstract: http://links.ealert.nature.com/ctt?kn=14&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=15&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin
X Wan, S Y Kim, L M Guenther, A Mendoza, J Briggs, C Yeung, D Currier, H Zhang, C Mackall, W-J Li, R S Tuan, A T Deyrup, C Khanna and L Helman
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=17&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells
J Dai, L Peng, K Fan, H Wang, R Wei, G Ji, J Cai, B Lu, B Li, D Zhang, Y Kang, M Tan, W Qian and Y Guo
Abstract: http://links.ealert.nature.com/ctt?kn=18&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=19&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

----------------------
SHORT COMMUNICATION
----------------------
Histone macroH2A isoforms predict the risk of lung cancer recurrence
J C Sporn, G Kustatscher, T Hothorn, M Collado, M Serrano, T Muley, P Schnabel and A G Ladurner
Abstract: http://links.ealert.nature.com/ctt?kn=20&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=21&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

---------------------------------------------------------------------

Ensure your access

If you are unable to access the articles in this Table of Contents e-alert, your
library may not subscribe to this journal. Our online recommendation form is a
simple way to make your librarian aware that this journal is valuable to your research.

Recommend now at http://links.ealert.nature.com/ctt?kn=60&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0

=====================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=39&m=34068041&r=MTc2ODI0Mjc1MwS2&b=2&j=NTgzOTYzMTQS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© Copyright 2009 Nature Publishing Group

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time